/

Società

Co

Non verificato

Countable Labs

Di cosa scriviamo

BiotecnologiaEventiOncologiaSaluteScienza

8 comunicati stampa

Guarda tutti i comunicati

23/07/2026

Industria

Scienza

Attrezzature medico-sanitarie

HIV, AIDS e malattie autoimmuni

Biotecnologia

Sanità

Salute

Oncologia

Countable Labs Announces Certified Service Provider Program, Broadening Access to the Countable PCR System

Fonte

Emittente

1.00

0

25/06/2026

Mercato del lavoro

Industria

Eventi

Oncologia

Salute

Biotecnologia

Sanità

Scienza

Countable Labs and Promega Announce Co-Marketing Agreement to Facilitate End-to End Biological Sample Preparation and Rare Variant Detection

Fonte

Emittente

1.00

0

28/05/2026

Oncologia

Salute

Biotecnologia

Scienza

Countable Labs Raises $26 Million to Accelerate Clinical Product Development and Global Commercialization of Countable PCR

Fonte

Emittente

1.00

0

11/05/2026

Eventi

Scienza

Biotecnologia

Oncologia

Salute

Attrezzature medico-sanitarie

HIV, AIDS e malattie autoimmuni

Countable Labs Addresses Critical Measurement Gaps in Cell and Gene Therapy

Fonte

Emittente

1.00

0

25/03/2026

Web e Social Network

Industria

Salute

HIV, AIDS e malattie autoimmuni

Biotecnologia

Scienza

Countable Labs Brings Innovative, Single-Molecule, Counting-Based PCR to European Markets with CE Mark Clearance

Fonte

Emittente

1.00

0

04/11/2025

Countable Labs Announces Additional Modules for Countable PCR Expanding its Utility for Translational Research, Cell and Gene Therapy Manufacturing, and Diagnostic Development

Fonte

Emittente

1.00

0

07/10/2025

Countable Labs Launches Revolutionary Ten-Color PCR Platform, Bridging the Gap Between PCR and Next-Generation Sequencing Technologies

Fonte

Emittente

1.00

0

13/05/2025

Eventi

Sanità

Salute

Biotecnologia

Scienza

Countable Labs Launches Category-defining, Highly Sensitive PCR Platform — Countable PCR — Finally Quantifying Rare Events, Even From Limited Samples

Fonte

Emittente

1.00

0

Seguaci

0

Compatibilità

0